Open AccessAntithrombin III injectionviathe portal vein suppresses liver damage
Author(s) -
Masaru Miyazaki,
Masaki Kato,
Masanori Tanaka,
Kosuke Tanaka,
Shinichiro Takao,
Motoyuki Kohjima,
Tetsuhide Ito,
Munechika Enjoji,
Makoto Nakamuta,
Kazuhiro Kotoh,
Ryoichi Takayanagi
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i16.1884
Subject(s) - fibrin , medicine , antithrombin , endocrinology , lipopolysaccharide , lactate dehydrogenase , tumor necrosis factor alpha , vein , chemistry , heparin , immunology , enzyme , biochemistry
To investigate the effects of antithrombin III (AT III) injection via the portal vein in acute liver failure.